Thermo Fisher Scientific Inc (NYSE:TMO) Big Money Sentiment Is 0.86

June 27, 2018 - By Daniel Cummings

Thermo Fisher Scientific Inc. (NYSE:TMO) Corporate Logo

Thermo Fisher Scientific Inc’s Sentiment

“Big money sentiment for Thermo Fisher Scientific Inc (NYSE:TMO) in 2018 Q1 decreased to 0.86, according to SEC filings. That’s down -0.05, from 2017Q4’s 0.91. 420 institutional investors increased and started new holdings, while 486 sold and decreased holdings in Thermo Fisher Scientific Inc so the sentiment turned negative. Funds own 331.98 million shares, down from 335.65 million shares in 2017Q4. Funds holding Thermo Fisher Scientific Inc in top 10 changed to 79 from 69 for an increase of 10. 42 Investors Sold All; 444 Reduced Holdings; 301 increased stakes while 119 institutional investors bought stakes.

Significant Thermo Fisher Scientific Inc Shareholders

Cryder Capital Partners Llp owns 247,513 shares in Thermo Fisher Scientific Inc as of 2018 Q1. As of 2018 Q1, 382,989 shares of Thermo Fisher Scientific Inc are owned by Veritas Investment Management Llp. Further, Caledonia Investments Plc reported 168,917 shares in Thermo Fisher Scientific Inc equivalent to 9.76% of its US long equity exposure. Veritas Investment Management (Uk) Ltd revealed 107,056 shares position in Thermo Fisher Scientific Inc. The California-based fund Grand Jean Capital Management Inc looks positive on Thermo Fisher Scientific Inc, having 92,985 shares.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.The company has $82.54 billion market cap. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets.The P/E ratio is 36.48. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

Ticker’s shares touched $205.15 during the last trading session after 0.11% change.Currently Thermo Fisher Scientific Inc. is uptrending after 23.57% change in last June 27, 2017. TMO has 946,309 shares volume. The stock outperformed the S&P 500 by 11.00%.

Thermo Fisher Scientific Inc. (NYSE:TMO) is anticipated to announce earnings on July, 25., as reported by RTT. Analysts predict $2.68 EPS, which is $0.38 up or 16.52 % from 2017’s $2.3 EPS. This could hit $1.08B profit for TMO assuming the current $2.68 EPS will become reality. After $2.50 EPS report previous quarter, Wall Street now forecasts 7.20 % EPS growth of Thermo Fisher Scientific Inc..

Shell Asset accumulated 33,681 shs or 0.14% of the stock. Cullen Capital Ltd Llc holds 4,500 shs. The Vermont-based Hanson & Doremus Investment Mngmt has invested 0.02% in Thermo Fisher Scientific Inc. (NYSE:TMO). State Street has invested 0.26% of its capital in Thermo Fisher Scientific Inc. (NYSE:TMO). Manufacturers Life The reported 0.21% of its capital in Thermo Fisher Scientific Inc. (NYSE:TMO). Pggm Invests has invested 0.22% in Thermo Fisher Scientific Inc. (NYSE:TMO). Transamerica Advsr Inc accumulated 0.11% or 3,675 shs. Miura Mngmt Llc has 140,000 shs for 5.76% of their capital. Wellington Shields Mngmt Lc holds 0.35% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 11,255 shs. 6,415 are owned by Quantbot Technologies Lp. Gabelli And Inv Advisers Inc accumulated 0.03% or 1,000 shs. Long Road Inv Counsel Lc stated it has 13,860 shs or 2% of all its holdings. Koshinski Asset Mngmt Incorporated holds 0.21% or 3,339 shs in its capital. Earnest Ptnrs Limited Liability owns 199 shs. Victory Cap Management accumulated 21,157 shs.

Thermo Fisher Scientific Inc. registered $48.68 million net activity with 0 buys and 11 selling transactions since February 2, 2018. On Friday, February 23 Shares for $211,430 were sold by Parrett William G. Williamson Stephen sold 2,500 shs worth $530,000. On Friday, June 15 CASPER MARC N sold $9.67 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO). On Friday, February 2 Shares for $7.32M were sold by Herrema Gregory J.. The insider HARRIS C MARTIN sold 206 shs worth $44,174.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

In total 9 analysts cover Thermo Fisher (NYSE:TMO). “Buy” rating has 8, “Sell” are 0, while 1 are “Hold”. (NYSE:TMO) has 89% bullish analysts. With $250 highest and $216 lowest PT, Thermo Fisher has $233.33 average PT or 13.74% above the current ($205.15) price. 12 are the (NYSE:TMO)’s ratings reports on 27 Jun 2018 according to StockzIntelligence Inc. In Thursday, February 1 report Barclays Capital maintained the stock with “Overweight” rating. On Thursday, February 1 the firm has “Hold” rating given by Jefferies. The company rating was maintained by Robert W. Baird on Thursday, January 18. On Wednesday, January 31 Robert W. Baird maintained Thermo Fisher Scientific Inc. (NYSE:TMO) with “Buy” rating. On Thursday, February 1 Leerink Swann maintained the shares of TMO in report with “Buy” rating. On Thursday, February 1 the rating was maintained by Morgan Stanley with “Overweight”. On Thursday, February 1 Bank of America maintained Thermo Fisher Scientific Inc. (NYSE:TMO) with “Buy” rating. The stock rating was maintained by Morgan Stanley with “Overweight” on Wednesday, April 11. On Wednesday, January 3 the rating was initiated by Evercore with “Buy”. On Wednesday, January 31 the stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given by Cowen & Co.

For more Thermo Fisher Scientific Inc. (NYSE:TMO) news brought out recently go to: Prnewswire.com, Seekingalpha.com, Globenewswire.com, Streetinsider.com or Gurufocus.com. The titles are as follows: “Diagnostics Play Critical Role in Medical Sector” brought out on June 26, 2018, “Thermo Fisher launches Ion AmpliSeq HD technology” on June 18, 2018, “Factors of Influence in 2018, Key Indicators and Opportunity within Dr Pepper Snapple Group, United Therapeutics …” with a publish date: June 25, 2018, “GE’s determined makeover could dim deal prospects” and the last “Thermo Fisher Scientific Inc (TMO) CEO Marc N Casper Sold $9.7 million of Shares” with publication date: June 19, 2018.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.